Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats

Yuji Ishibashi, Fumiyoshi Kobayashi, Akira Idesawa, Akiyoshi Taniguchi, Shigeki Matsuzawa

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Carbocisteine is a mucoregulatory drug regulating fucose and sialic acid contents in mucus glycoprotein. To investigate the mechanism of carbocisteine action, we evaluated the effects of carbocisteine on the activity of fucosidase, sialidase, fucosyltransferase and sialyltransferase, and on the expression of Muc5ac mRNA in the airway epithelium of SO2-exposed rats. Wistar rats were repeatedly exposed to a 300-ppm SO2 gas for 44 days. Carbocisteine (125 and 250 mg/kg ×2/day) was administered for 25 days after 20 days of SO2 gas exposure. These enzyme activities were measured by fluorogenic substrate or glycoproteinic exogenous acceptor method. The expression levels of Muc5ac mRNA and protein were determined with real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Carbocisteine (250 mg/kg ×2/day) inhibited all the changes in these enzyme activities and the expressions of Muc5ac mRNA and protein in the lung after repeated SO 2 exposure. These findings suggest that carbocisteine may normalize fucose and sialic acid contents in mucin glycoprotein through regulation of these enzyme activities, and inhibition of both Muc5ac mRNA and protein expressions in SO2-exposed rats.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalEuropean Journal of Pharmacology
Volume487
Issue number1-3
DOIs
Publication statusPublished - 2004 Mar 8
Externally publishedYes

Fingerprint

Glycosyltransferases
Glycoside Hydrolases
Messenger RNA
Fucose
N-Acetylneuraminic Acid
Real-Time Polymerase Chain Reaction
Enzymes
Gases
alpha-L-Fucosidase
Fucosyltransferases
Sialyltransferases
Proteins
Neuraminidase
Mucins
Reverse Transcriptase Polymerase Chain Reaction
Fluorescent Dyes
Wistar Rats
Glycoproteins
Epithelium
Enzyme-Linked Immunosorbent Assay

Keywords

  • Carbocisteine
  • Fucosidase
  • Fucosyltransferase
  • Muc5ac
  • Sialidase
  • Sialyltransferase

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats. / Ishibashi, Yuji; Kobayashi, Fumiyoshi; Idesawa, Akira; Taniguchi, Akiyoshi; Matsuzawa, Shigeki.

In: European Journal of Pharmacology, Vol. 487, No. 1-3, 08.03.2004, p. 7-15.

Research output: Contribution to journalArticle

Ishibashi, Yuji ; Kobayashi, Fumiyoshi ; Idesawa, Akira ; Taniguchi, Akiyoshi ; Matsuzawa, Shigeki. / Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats. In: European Journal of Pharmacology. 2004 ; Vol. 487, No. 1-3. pp. 7-15.
@article{a9bc606c73174341b84dd2cd5fe2ea85,
title = "Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats",
abstract = "Carbocisteine is a mucoregulatory drug regulating fucose and sialic acid contents in mucus glycoprotein. To investigate the mechanism of carbocisteine action, we evaluated the effects of carbocisteine on the activity of fucosidase, sialidase, fucosyltransferase and sialyltransferase, and on the expression of Muc5ac mRNA in the airway epithelium of SO2-exposed rats. Wistar rats were repeatedly exposed to a 300-ppm SO2 gas for 44 days. Carbocisteine (125 and 250 mg/kg ×2/day) was administered for 25 days after 20 days of SO2 gas exposure. These enzyme activities were measured by fluorogenic substrate or glycoproteinic exogenous acceptor method. The expression levels of Muc5ac mRNA and protein were determined with real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Carbocisteine (250 mg/kg ×2/day) inhibited all the changes in these enzyme activities and the expressions of Muc5ac mRNA and protein in the lung after repeated SO 2 exposure. These findings suggest that carbocisteine may normalize fucose and sialic acid contents in mucin glycoprotein through regulation of these enzyme activities, and inhibition of both Muc5ac mRNA and protein expressions in SO2-exposed rats.",
keywords = "Carbocisteine, Fucosidase, Fucosyltransferase, Muc5ac, Sialidase, Sialyltransferase",
author = "Yuji Ishibashi and Fumiyoshi Kobayashi and Akira Idesawa and Akiyoshi Taniguchi and Shigeki Matsuzawa",
year = "2004",
month = "3",
day = "8",
doi = "10.1016/j.ejphar.2003.12.038",
language = "English",
volume = "487",
pages = "7--15",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats

AU - Ishibashi, Yuji

AU - Kobayashi, Fumiyoshi

AU - Idesawa, Akira

AU - Taniguchi, Akiyoshi

AU - Matsuzawa, Shigeki

PY - 2004/3/8

Y1 - 2004/3/8

N2 - Carbocisteine is a mucoregulatory drug regulating fucose and sialic acid contents in mucus glycoprotein. To investigate the mechanism of carbocisteine action, we evaluated the effects of carbocisteine on the activity of fucosidase, sialidase, fucosyltransferase and sialyltransferase, and on the expression of Muc5ac mRNA in the airway epithelium of SO2-exposed rats. Wistar rats were repeatedly exposed to a 300-ppm SO2 gas for 44 days. Carbocisteine (125 and 250 mg/kg ×2/day) was administered for 25 days after 20 days of SO2 gas exposure. These enzyme activities were measured by fluorogenic substrate or glycoproteinic exogenous acceptor method. The expression levels of Muc5ac mRNA and protein were determined with real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Carbocisteine (250 mg/kg ×2/day) inhibited all the changes in these enzyme activities and the expressions of Muc5ac mRNA and protein in the lung after repeated SO 2 exposure. These findings suggest that carbocisteine may normalize fucose and sialic acid contents in mucin glycoprotein through regulation of these enzyme activities, and inhibition of both Muc5ac mRNA and protein expressions in SO2-exposed rats.

AB - Carbocisteine is a mucoregulatory drug regulating fucose and sialic acid contents in mucus glycoprotein. To investigate the mechanism of carbocisteine action, we evaluated the effects of carbocisteine on the activity of fucosidase, sialidase, fucosyltransferase and sialyltransferase, and on the expression of Muc5ac mRNA in the airway epithelium of SO2-exposed rats. Wistar rats were repeatedly exposed to a 300-ppm SO2 gas for 44 days. Carbocisteine (125 and 250 mg/kg ×2/day) was administered for 25 days after 20 days of SO2 gas exposure. These enzyme activities were measured by fluorogenic substrate or glycoproteinic exogenous acceptor method. The expression levels of Muc5ac mRNA and protein were determined with real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Carbocisteine (250 mg/kg ×2/day) inhibited all the changes in these enzyme activities and the expressions of Muc5ac mRNA and protein in the lung after repeated SO 2 exposure. These findings suggest that carbocisteine may normalize fucose and sialic acid contents in mucin glycoprotein through regulation of these enzyme activities, and inhibition of both Muc5ac mRNA and protein expressions in SO2-exposed rats.

KW - Carbocisteine

KW - Fucosidase

KW - Fucosyltransferase

KW - Muc5ac

KW - Sialidase

KW - Sialyltransferase

UR - http://www.scopus.com/inward/record.url?scp=1642277078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642277078&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2003.12.038

DO - 10.1016/j.ejphar.2003.12.038

M3 - Article

C2 - 15033371

AN - SCOPUS:1642277078

VL - 487

SP - 7

EP - 15

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -